The USFDA's Establishment Inspection Report for the Andhra facility is given to Dr. Reddy's.

Drug manufacturer Dr. Reddy's Laboratories Ltd., based in Hyderabad, has notified stock markets that the US Food and Drug Administration (USFDA) has granted its Srikakulam, Andhra Pradesh, manufacturing facility Voluntary Action Indicated (VAI) status. According to the company, on October 20, 2025, it obtained the Establishment Inspection Report (EIR). The USFDA declared the inspection to be formally closed after classifying the results as VAI. Dr. Reddy's had previously disclosed that the USFDA had performed a Pre-Approval examination (PAI) and a Good Manufacturing Practices (GMP) examination at its formulations facility.